Targacept starts new trial for diabetes drug – Bizjournals.com

Targacept starts new trial for diabetes drug
Bizjournals.com
Targacept will take a drug it hopes will become a treatment for asthma and Type 2 diabetes into a Phase 2 clinical trial, the company has announced.
Targacept to begin phase 2 trials for its anti-inflammatory drug compoundWinston-Salem Journal
TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and 4-traders (press release)

all 12 news articles »

View full post on asthma – Google News

VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma – Trading Markets (press release)


Proactive Investors UK

VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma
Trading Markets (press release)
This study is the first of two further trials with RPL554 in patients with allergic asthma. Based on the results, it will determine the dosage used in a
Verona Pharma starts Asthma drug trialProactive Investors UK
STOCKS NEWS UK-Verona gains positive update on key drugLondon South East
Verona Pharma up 20% on new drug trialStock Market Wire
Trading Markets (press release)
all 11 news articles »

View full post on asthma – Google News

Early Trial Suggests COPD Drug Might Help Some Asthmatics – BusinessWeek

Early Trial Suggests COPD Drug Might Help Some Asthmatics
BusinessWeek
19 (HealthDay News) — For asthma patients whose condition is not controlled with standard inhaled steroids, the addition of Spiriva — a medication already
Adding Another Drug Beats Doubling Dose in AsthmaMedPage Today
Spiriva is an alternative for adult asthmatics, researchers sayLos Angeles Times
Possible alternate therapy for adults with poorly controlled asthmaEurekAlert (press release)

all 12 news articles »

View full post on asthma – Google News